Impact of the american heart association scientific statement on screening electrocardiograms and stimulant medications

Archives of Pediatrics and Adolescent Medicine

Volumn 165, Issue 2, 2011, Pages 166-170

  Thomas, Patricia Elizabeth ^a,b   Carlo, Waldemar F ^a,c   Decker, Jamie A ^a   Cannon, Bryan C ^a,d   Kertesz, Naomi J ^a,e   Friedman, Richard A ^a   Kim, Jeffrey J ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b OCHSNER MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

^d MAYO CLINIC   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL PRACTICE; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEALTH CARE COST; HUMAN; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PEDIATRICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; TERTIARY HEALTH CARE; THERAPY DELAY; UNITED STATES;

ADOLESCENT; AMERICAN HEART ASSOCIATION; ARRHYTHMIAS, CARDIAC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; ELECTROCARDIOGRAPHY; HUMANS; MASS SCREENING; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TEXAS; UNITED STATES;

EID: 79751500143     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2010.278     Document Type: Article

References (22)

1. Richters JE, Arnold LE, Jensen PS, et al. NIMH collaborative multisite multimodal treatment study of children with ADHD, I: background and rationale. J Am Acad Child Adolesc Psychiatry. 1995;34(8):987-1000.
2. Wilens TE, Prince JB, Spencer TJ, Biederman J. Stimulants and sudden death: what is a physician to do? Pediatrics. 2006;118(3):1215-1219. (Pubitemid 46090066)
3. Barbaresi WJ, Katusic SK, Colligan RC, et al. How common is attention-deficit/hyperactivity disorder? incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002;156(3):217-224. (Pubitemid 34205431)
4. Brown RT, Freeman WS, Perrin JM, et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics. 2001;107 (3):e43. http://pediatrics.aappublications.org/cgi/content/full/107/3/ e43. Accessed June 1, 2009.
5. Centers for Disease Control and Prevention. Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder - United States, 2003.MMWRMorb Mortal Wkly Rep. 2005;54(34):842-847.
6. Nissen SE. ADHD drugs and cardiovascular risk. N Engl JMed. 2006;354(14):1445-1448.
7. US Food and Drug Administration. Pediatric Advisory Committee: briefing information. March 22, 2006. http://www.fda.gov/ohrms/dockets/ac/06/slides/2006- 4210s-index.htm. Accessed June 1, 2009.
8. Biederman J, Spencer TJ, Wilens TE, Prince JB, Faraone SV. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. J Am Acad Child Adolesc Psychiatry. 2006;45(10):1147-1150. (Pubitemid 44465634)
9. US Food and Drug Administration. Public health advisory for Adderall and Adderall XR. August 2005. http://www.fda.gov/drugs/drugsafety/ postmarketdrugsafetyinformationforpatientsandproviders/ucm111441.htm. Accessed June 1, 2009.
10. US Food and Drug Administration. Detailed view: safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER). August 2005. http://www.fda.gov/medwatch/safety/2005/aug05.htm. Accessed June 1, 2009.
11. Vetter VL, Elia J, Erickson C, et al; American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee; American Heart Association Council on Cardiovascular Nursing. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing [published correction appears in Circulation. 2009 Aug 18;120(7):e55-9]. Circulation. 2008;117:2407-2423.
12. Perrin JM, Friedman RA, Knilans TK; Black Box Working Group; Section on Cardiology and Cardiac Surgery. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics. 2008;122(2):451-453.
13. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527-530. (Pubitemid 29189000)
14. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342(8883):1317-1322. (Pubitemid 23345178)
15. Davis DA, Taylor-Vaisey A. Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997;157(4):408-416. (Pubitemid 27384745)
16. Mahle WT, Hebson C, Strieper MJ. Electrocardiographic screening for cardiac disease among children with attention deficit disorder [abstract 1026-230]. J Am Coll Cardiol. March 10 2009;53:A360. http://content.onlinejacc. org/cgi/reprint/53/10-Suppl-A/A355.pdf. Accessed June 1, 2009.
17. Strine TW, Lesesne CA, Okoro CA, et al. Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attentiondeficit/hyperactivity disorder. Prev Chronic Dis. 2006;3(2):A52. http://www.cdc.gov/pcd/issues/2006/apr/05-0171.htm. Accessed June 1, 2009.
18. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192-202. (Pubitemid 43151524)
19. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry. 2004;45(2):195-211. (Pubitemid 38240269)
20. Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME. Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1222-1227. (Pubitemid 27381278)
21. Bagwell CL, Molina BS, Pelham WE Jr, Hoza B. Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry. 2001;40(11):1285-1292. (Pubitemid 32995796)
22. Spencer TS, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996;35(4):409-432. (Pubitemid 126418605)